Fulvestrant Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
OLMA | D | Olema Pharmaceuticals, Inc. | 2.50 | |
GTHX | F | G1 Therapeutics, Inc. | 4.90 |
Related Industries: Biotechnology
Related Stock Lists:
Antiestrogens
Biopharmaceutical
Breast Cancer
Estrogen
Estrogen Receptor
Her2
Her2/Neu
Hormones
Selective Estrogen Receptor Degraders
Treatment Of Breast Cancer
Cancer
Clinical Medicine
Drugs
Epidermal Growth Factor Receptor
Medicine
Protein Kinase Inhibitor
Receptor Positive
Targeted Therapy
Treatment Of Cancer
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.85 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.47 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 0.42 | |
XBI | C | SPDR S&P Biotech ETF | 0.16 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.16 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jul 1 | GTHX | G1 Therapeutics added to the Russell 2000® and 3000® Indexes |
Jul 1 | GTHX | G1 Therapeutics Added to the Russell 2000® and 3000® Indexes |
Related Industries:
Biotechnology
Related Stock Lists:
Antiestrogens
Biopharmaceutical
Breast Cancer
Estrogen
Estrogen Receptor
Her2
Her2/Neu
Hormones
Selective Estrogen Receptor Degraders
Treatment Of Breast Cancer
Cancer
Clinical Medicine
Drugs
Epidermal Growth Factor Receptor
Medicine
Protein Kinase Inhibitor
Receptor Positive
Targeted Therapy
Treatment Of Cancer
- Fulvestrant
Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.Fulvestrant is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.Fulvestrant was approved for medical use in the United States in 2002.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles